AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Vildagliptin 50 Mg ;

16 registrations across 1 African market— 16 active

Markets with Vildagliptin 50 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Zolavintine
Tablets
🇪🇬EgyptSIGMA PHARMACEUTICAL INDUSTRIESactive
Gliptanza
Tablets
🇪🇬EgyptNew Boston Pharmaceuticalactive
Vildamilleto
Tablets
🇪🇬EgyptGlobal Advanced pharmaceuticals "GAP"active
Vanvilda
Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
viliglap
Tablets
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive
Sugarlo
Tablets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
GLIPTUS
Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Galvus ® 50 mg
Tablets
🇪🇬EgyptNovartis Pharmaactive
Gliptanza
Tablets
🇪🇬EgyptNew Boston Pharmaceuticalactive
viliglap
Tablets
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive
Sugarlo
Tablets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
GLIPTUS
Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Vildamilleto
Tablets
🇪🇬EgyptGlobal Advanced pharmaceuticals "GAP"active
Vanvilda
Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Zolavintine
Tablets
🇪🇬EgyptSIGMA PHARMACEUTICAL INDUSTRIESactive
Galvus ® 50 mg
Tablets
🇪🇬EgyptNovartis Pharmaactive

Vildagliptin 50 Mg ; in Africa — Regulatory Overview

Vildagliptin 50 Mg ; is registered across 1 African markets with 16 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 16 registrations, 16 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.